Data / Form D filings / Savanna Biotherapeutics, Inc.
Savanna Biotherapeutics, Inc.: Form D filings
Savanna Biotherapeutics, Inc., a biotechnology company in Aliso Viejo, CA, filed 2 Form D notices with the SEC between 2022 and 2025. The latest, on June 30, 2025, reports $13 million sold of a $60 million offering to 30 investors.
SpecStream is the live web data engine for teams and agents. It reads every Form D on SEC EDGAR the day it is filed, and this page is that reading. Ask for your own cut (a state, an industry, a size) and new filings arrive in your sheet, CRM, Slack or agent as they land.
Company details from the filing
- Address
- C/O UNIVERSITY LAB PARTNERS, CURIE HALL, 1 UNIVERSITY DRIVE, Aliso Viejo, CA, 92656
- Phone
- (716) 969-2573
- Industry
- Biotechnology
- Entity type
- Corporation
- Incorporated in
- Delaware
- Year incorporated
- 2020
- Revenue range
- Decline to Disclose
- Exemptions claimed
- Rule 506(b)
- SEC identifier (CIK)
- 1873404
Form D filings
| Filed | Type | Offering | Sold | Remaining | Investors | First sale | Filing |
|---|---|---|---|---|---|---|---|
| Jun 30, 2025 | New notice | $59,999,993 | $12,999,997 | $46,999,996 | 30 | Jun 12, 2025 | sec.gov |
| Nov 18, 2022 | New notice | $54,304,476 | $24,304,480 | $29,999,996 | 54 | Nov 3, 2022 | sec.gov |
Executive officers and directors named in the filing
| Name | Role | Note in the filing |
|---|---|---|
| Jeffrey W. Bird | Director | |
| Robert Spitale | Executive Officer, Director | |
| Keith W. Loebner | Director | |
| Kim W. Kamdar | Director |
Other biotechnology companies in California that filed recently
- Trellis Bioscience, Inc. $9.1 million · Oct 29, 2026
- BigHat Biosciences, Inc. $75.1 million · Oct 26, 2026
- Theravie Pharma, Inc. $750,000 · Oct 19, 2026
- Adela, Inc. $12 million · Oct 19, 2026
- Estuary Biotherapeutics, Inc. $40.7 million · Oct 16, 2026
- Renue Life Sciences, Inc. $250,000 · Oct 14, 2026
Every Form D from the week of Jun 30, 2025 · All recent filings in California · All recent Biotechnology filings
Read from SEC EDGAR. Amount sold is what Savanna Biotherapeutics, Inc. reported on the day it filed; on an offering that is still open, a later amendment can raise it. Free to reuse with credit to SpecStream under CC BY 4.0.